Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Colleen Tupper Biography and Net Worth

Exec. VP & CFO of Collegium Pharmaceutical

Colleen Tupper joined Collegium Pharmaceutical in May 2021 as Executive Vice President and Chief Financial Officer. Prior to joining Collegium, Colleen most recently served as Chief Financial Officer, U.S. Business Unit as well as a member of the U.S. Business Unit Executive Leadership Team and the Global Finance Leadership Team at Takeda. Prior to that role, Colleen held several roles of increasing responsibility at Shire Pharmaceuticals (acquired by Takeda in 2019) including Vice President, U.S. Commercial Finance, Vice President, Finance Integration Lead, and Vice President, Head of Finance Global Neuroscience and Ophthalmics. Earlier in her career, Ms. Tupper served in various finance and accounting roles at both Shire Pharmaceuticals and Antigenics (now Agenus). Ms. Tupper received a B.S. in Accounting from Franklin Pierce University.

How old is Colleen Tupper?: Ms. Tupper is currently 48 years old. There are 5 older executives and no younger executives at Collegium Pharmaceutical. The oldest executive at Collegium Pharmaceutical is Dr. Thomas B. Smith FAAFP, M.D., Executive VP & Chief Medical Officer, who is 63 years old. Learn More on Colleen Tupper's age.
How do I contact Colleen Tupper?: The corporate mailing address for Ms. Tupper and other Collegium Pharmaceutical executives is 100 Technology Center Drive, Stoughton MA, 02072. Collegium Pharmaceutical can also be reached via phone at (781) 713-3699 and via email at [email protected]. Learn More on Colleen Tupper's contact information.
Has Colleen Tupper been buying or selling shares of Collegium Pharmaceutical?: Colleen Tupper has not been actively trading shares of Collegium Pharmaceutical during the past quarter. Learn More on Colleen Tupper's trading history.
Who are Collegium Pharmaceutical's active insiders?: Collegium Pharmaceutical's insider roster includes Joseph Ciaffoni (Pres), Scott Dreyer (EVP), Michael Heffernan (Director), Shirley Kuhlmann (EVP), and Colleen Tupper (Exec. VP & CFO ). Learn More on Collegium Pharmaceutical's active insiders.
Are insiders buying or selling shares of Collegium Pharmaceutical?: During the last year, insiders at the specialty pharmaceutical company sold shares 9 times. They sold a total of 202,376 shares worth more than $6,618,056.46. The most recent insider tranaction occured on September, 13th when EVP Thomas B Smith sold 9,593 shares worth more than $351,295.66. Insiders at Collegium Pharmaceutical own 4.0% of the company. Learn More about insider trades at Collegium Pharmaceutical.
Information on this page was last updated on 9/13/2024.

Colleen Tupper Insider Trading History at Collegium Pharmaceutical

Colleen Tupper Buying and Selling Activity at Collegium Pharmaceutical

Collegium Pharmaceutical Company Overview

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Today's Range

Now: $29.58

$29.17

$30.65

50 Day Range

MA: $36.36

$29.58

$41.86

2 Week Range

Now: $29.58

$24.61

$42.29

Volume

605,403 shs

Average Volume

418,211 shs

Market Capitalization

$953.96 million

P/E Ratio

12.75

Dividend Yield

N/A

Beta

0.95

This company will win the AI race

From Porter & Company | Ad